Fig. 3
From: Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC
Sensitivity and Specificity of CRP and WBC counts after HIPEC. The specifitiy of CRP after CRS/HIPEC is only 49.9% (A). Specificity is reduced after mitomycinC and cisplatin based HIPEC to 37.3% and 39.9% respecitivly (B). WBC counts demonstrate a low sensitivity of 36.4% in general (C), pronounced after prolonged protocols with mitomycin C or cisplatin (D). SENS, sensitivity; SPEC, specificity; PPV, positive predictive value; NPV, negative predictive value